FDA NDC Directory · JSON-LD · Markdown

HYRIMOZ

NDC 61314-473 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameadalimumab-adaz
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761071
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (40 mg/.4mL)
Marketing started20230701
Package count3

External sources

Source: openFDA. Public-domain (CC0).